Clinical Trial Update: Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial assessing perifosine in combination with docetaxel in patients with relapsed epithelial ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Perifosine (perifosine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED